SQZ Biotechnologies (SQZ)
NYSE: SQZ
· Real-Time Price · USD
0.43
0.16 (59.26%)
At close: Jul 03, 2023, 7:00 PM
SQZ Biotechnologies Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 12.2M | 15.33M | 18.16M | 21.02M | 21.36M | 22.98M | 24.51M | 27.1M | 17.23M | 18.6M | 20.04M |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 12.2M | 15.33M | 18.16M | 21.02M | 21.36M | 22.98M | 24.51M | 27.1M | 17.23M | 18.6M | 20.04M |
Operating Income | -73.19M | -72.49M | -77.89M | -80.68M | -78.48M | -77.83M | -74.41M | -68.76M | -74.55M | -64.5M | -55.51M |
Interest Income | 1.62M | 1.9M | 1.71M | 1.22M | 615K | 187K | 42K | 36K | 45K | 93K | 185K |
Pretax Income | -48M | -70.65M | -76.11M | -79.46M | -77.74M | -77.55M | -74.38M | -68.74M | -74.52M | -64.42M | -55.34M |
Net Income | -3.4M | -25.59M | -31.05M | -34.97M | -77.28M | -77.55M | -74.38M | -68.74M | -74.52M | -64.42M | -55.34M |
Selling & General & Admin | 20.98M | 22.29M | 24.69M | 26.32M | 27.76M | 27.54M | 26.51M | 25.72M | 25.12M | 23.04M | 21.13M |
Research & Development | 51.79M | 60.92M | 66.95M | 70.98M | 72.61M | 73.5M | 72.42M | 70.15M | 66.67M | 60.06M | 54.42M |
Other Expenses | 7.82M | -186K | -73K | -136K | -211K | 111K | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 80.53M | 82.96M | 91.18M | 96.85M | 99.84M | 100.83M | 98.93M | 95.87M | 91.79M | 83.1M | 75.55M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 80.53M | 82.96M | 91.18M | 96.85M | 99.84M | 100.83M | 98.93M | 95.87M | 91.79M | 83.1M | 75.55M |
Income Tax Expense | -44.95M | -45.4M | -45.22M | -44.65M | -602K | -141K | 21K | 28K | 33K | 77K | 171K |
Shares Outstanding (Basic) | 29.49M | 29.49M | 29.49M | 28.81M | 29.28M | 28.37M | 28.15M | 28.05M | 28.05M | 27.92M | 26.26M |
Shares Outstanding (Diluted) | 29.49M | 29.49M | 29.49M | 28.81M | 29.28M | 28.37M | 28.15M | 28.05M | 28.05M | 27.92M | 26.26M |
EPS (Basic) | -0.09 | -0.85 | -1.06 | -1.23 | -2.71 | -2.75 | -2.65 | -2.49 | -3.29 | -3.01 | -2.89 |
EPS (Diluted) | -0.09 | -0.85 | -1.06 | -1.23 | -2.71 | -2.75 | -2.65 | -2.49 | -3.29 | -3.01 | -2.89 |
EBITDA | -59.65M | -56.09M | -61.04M | -64.14M | -67.47M | -66.89M | -63.41M | -57.71M | -63.43M | -53.26M | -44.29M |
EBIT | -13.72M | -13.72M | -13.72M | -13.72M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Depreciation & Amortization | 13.51M | 16.4M | 16.84M | 16.54M | 11.01M | 10.94M | 10.98M | 11.03M | 11.09M | 11.16M | 11.05M |